Skip to main content
. 2021 Dec 24;15:4809–4816. doi: 10.2147/OPTH.S340041

Figure 1.

Figure 1

PPS dosage and usage.

Notes: (A) groups the number of patients grouped based on the duration of PPS use, and (B) groups the patients based on the different cumulative dosages of PPS use. There was a relatively higher proportion of patients with higher dosages and duration in the PPS-associated retinopathy group.